Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR0191 in Subjects with Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03666000
Protocol Number
NSH1270
Phase
I/II
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Lymphoid Leukemia
Non-Hodgkin's Lymphoma
Sponsor Protocol
PBCAR0191-01
Principal Investigator
Scott Solomon
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us